tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

CHRS Stock Latest News

Coherus Announces Industry-Wide Lowest List Price for Adalimumab Biosimilar YUSIMRY™ (adalimumab-aqvh) Launching in July 2023
Press ReleasesCoherus Announces Industry-Wide Lowest List Price for Adalimumab Biosimilar YUSIMRY™ (adalimumab-aqvh) Launching in July 2023
21h ago
CHRS
Mark Cuban Cost Plus Drug Company joins forces with Coherus to make YUSIMRY™, a HUMIRA® biosimilar, available to patients
Press ReleasesMark Cuban Cost Plus Drug Company joins forces with Coherus to make YUSIMRY™, a HUMIRA® biosimilar, available to patients
21h ago
CHRS
Coherus Announces U.S. Launch of UDENYCA® Autoinjector
Press ReleasesCoherus Announces U.S. Launch of UDENYCA® Autoinjector
11d ago
CHRS
Coherus Prices Public Offering of Common Stock
Press ReleasesCoherus Prices Public Offering of Common Stock
17d ago
CHRS
Coherus Announces Proposed Public Offering of Common Stock
Press ReleasesCoherus Announces Proposed Public Offering of Common Stock
18d ago
CHRS
3 Best Stocks to Buy Now, 5/9/2023, According to Top Analysts
Stock Analysis & Ideas3 Best Stocks to Buy Now, 5/9/2023, According to Top Analysts
24d ago
KKR
BIDU
Coherus BioSciences to Present at Upcoming Investor Conferences in May
Press ReleasesCoherus BioSciences to Present at Upcoming Investor Conferences in May
29d ago
CHRS
Coherus BioSciences to Report First Quarter 2023 Financial Results on May 8, 2023
Press ReleasesCoherus BioSciences to Report First Quarter 2023 Financial Results on May 8, 2023
1M ago
CHRS
Coherus Biosciences initiated with a Buy at Truist
The FlyCoherus Biosciences initiated with a Buy at Truist
1M ago
AMGN
CHRS
Coherus and Junshi Biosciences Announce Toripalimab Studies to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Press ReleasesCoherus and Junshi Biosciences Announce Toripalimab Studies to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
1M ago
CHRS
FDA resuming China lab inspections could benefit Amicus, BeiGene, Barron’s says
The FlyFDA resuming China lab inspections could benefit Amicus, BeiGene, Barron’s says
2M ago
BGNE
CHRS
Coherus Biosciences management to meet with Truist
The FlyCoherus Biosciences management to meet with Truist
2M ago
CHRS
Coherus Biosciences upgraded to Buy from Neutral at UBS
The FlyCoherus Biosciences upgraded to Buy from Neutral at UBS
2M ago
CHRS
Coherus Biosciences management to meet with Truist
The FlyCoherus Biosciences management to meet with Truist
2M ago
CHRS
Coherus Biosciences management to meet with Truist
The FlyCoherus Biosciences management to meet with Truist
2M ago
CHRS
Coherus Biosciences price target raised to $23 from $21 at Mizuho
The FlyCoherus Biosciences price target raised to $23 from $21 at Mizuho
3M ago
CHRS
Coherus Biosciences management to meet with Mizuho
The FlyCoherus Biosciences management to meet with Mizuho
3M ago
CHRS
Coherus Biosciences management to meet with Mizuho
The FlyCoherus Biosciences management to meet with Mizuho
3M ago
CHRS
Coherus Biosciences price target lowered to $13 from $15 at Barclays
The FlyCoherus Biosciences price target lowered to $13 from $15 at Barclays
3M ago
CHRS
Coherus Biosciences price target lowered to $26 from $30 at H.C. Wainwright
The FlyCoherus Biosciences price target lowered to $26 from $30 at H.C. Wainwright
3M ago
CHRS
Coherus Biosciences reports Q4 EPS (60c), consensus (84c)
The FlyCoherus Biosciences reports Q4 EPS (60c), consensus (84c)
3M ago
CHRS
Coherus BioSciences Reports Fourth Quarter and Full Year 2022 Results
Press ReleasesCoherus BioSciences Reports Fourth Quarter and Full Year 2022 Results
3M ago
CHRS